Dietary folate and the risk of nonfatal myocardial infarction

Epidemiology

Volumn 13, Issue 6, 2002, Pages 700-706

  Hernández Díaz, Sonia ^a   Martínez Losa, Ernesto ^b,d   Fernández Jarne, Elena ^b,c   Serrano Martínez, Manuel ^b,d   Martínez González, Miguel A ^b  

^a BOSTON UNIVERSITY   (United States)

^b UNIVERSITY OF NAVARRA   (Spain)

^c UNIVERSITY CLINIC OF NAVARRA   (Spain)

^d Navarre Primary Care Health Services   (Spain)

Author keywords

Case control study; Coronary heart disease; Folic acid; Mediterranean diet

Indexed keywords

FOLIC ACID; HOMOCYSTEINE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE SEVERITY; FOOD INTAKE; FRUIT; HEART INFARCTION; HUMAN; LEAFY VEGETABLE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; CASE CONTROL STUDY; FEMALE; MALE; MEDITERRANEAN SEA; MIDDLE AGED; NUTRITION; RISK; SPAIN; TIME;

CASE-CONTROL STUDIES; FEMALE; FOLIC ACID; HUMANS; MALE; MEDITERRANEAN SEA; MIDDLE AGED; MYOCARDIAL INFARCTION; NUTRITION SURVEYS; ODDS RATIO; RISK; SPAIN; TIME FACTORS;

EID: 0036832310     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001648-200211000-00015     Document Type: Article

References (47)

1. McCully K, Wilson R. Homocysteine theory of arteriosclerosis. Atherosclerosis 1975;22:215-227.
2. Boushey CJ, Beresford SAA, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA 1995;274:1049-1057.
3. Moghadasian MH, McManus BM, Frohlich JJ. Homocyst(e)ine and coronary artery disease: clinical evidence and genetic and metabolic background. Arch Intern Med 1997;157:2299-2308.
4. Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med 1998;338:1042-1050.
5. Kuller LH, Evans RW. Homocysteine, vitamins, and cardiovascular disease. Circulation 1998;98:196-199.
6. Cleophas TJ, Hornstra N, van Hoogstraten B, van der Meulen J. Homocysteine, a risk factor for coronary artery disease or not? A meta-analysis. Am J Cardiol 2000;86:1005-1009.
7. Homocysteine Lowering Trialists' Collaboration. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. BMJ 1998;316:894-898.
8. Malinow MR, Duell PB, Hess DL, et al. Reduction of plasma homocysteine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease. N Engl J Med 1998;338:1009-1015.
9. Verhoef P, Stampfer MJ, Buring JE, et al. Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate. Am J Epidemiol 1996;143:845-859.
10. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Willett W. Dietary folate, vitamin B6, and vitamin B12 intake and risk of CHD among a large population of US men. Circulation 1996;93:625.
11. Rimm EB, Willett W, Hu FB, et al. Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA 1998;279:359-364.
12. Voutilainen S, Rissanen T, Virtanen J, Lakka T, Salonen J. Low dietary folate intake is associated with an excess incidence of acute coronary events. The Kuopio Ischemic Heart Disease Risk Factor Study. Circulation 2001;103:2674-2680.
13. Bazzano LA, He J, Ogden L, et al. Dietary intake of folate and risk of stroke in US men and women: NHANES I epidemiologic follow-up study. Stroke 2002;33:1183-1189.
14. Fernández-Jarne E, Martínez-Losa E, Prado-Santamaría M, Brugarolas-Brufau C, Serrano-Martínez M, Martínez- González M. Risk of first non-fatal myocardial infarction negatively associated with olive oil consumption: a case-control study in Spain. Int J Epidemiol 2002;31:474-480.
15. Fernández-Jarne E, Alegre Garrido F, Alonso Gutiérrez A, De la Fuente Arrillaga C, Martínez-González M. Dietary intake of n-3 fatty acids and the risk of acute myocardial infarction: a case-control study (in Spanish). Med Clin (Barc.) 2002;118:121-125.
16. The effect of female sex hormones on fetal development and infant health. World Health Organiz Tech Rep Ser 1981;657:1-76.
17. Martin-Moreno J, Boyle P, Gorgojo L, et al. Development and validation of a food frequency questionnaire in Spain. Int J Epidemiol 1993;22:512-519.
18. Paffenbarger R, Wing A, Hyde R. Physical activity as an index of heart attack risk in college alumni. Am J Epidemiol 1978;108:161-175.
19. Ainsworth B, Haskell W, Whitt M. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000;32(9 suppl):S498-S504.
20. Walker AM. Observation and Inference: An Introduction to the Methods of Epidemiology. Newton Lower Falls, MA: Epidemiology Resources Inc., 1991.
21. Willett W, Stampfer MJ. Implications of total energy intake for epidemiologic analysis. In: Willett W, ed. Nutritional Epidemiology. 2nd ed. New York: Oxford University Press, 1998;273-301.
22. Loria CM, Ingram DD, Feldman JJ, Wright JD, Madans JH. Serum folate and cardiovascular disease mortality among US men and women. Arch Intern Med 2000;160:3258-3262.
23. Wald DS, Bishop L, Wald N, et al. Randomized trial of folic acid supplementation and serum homocysteine levels. Arch Intern Med 2001;161:695-700.
24. Cuskelly GJ, McNulty H, Scott JM. Effect of increasing dietary folate on red-cell folate: implications for prevention of neural tube defects. Lancet 1996;347:657-659.
25. Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997;337:230-236.
26. Morrison HI, Schaubel D, Desmeules M, Wigle DT. Serum folate and risk of fatal coronary heart disease. JAMA 1996;275:1893-1896.
27. Silberberg JS, Crooks RL, Wlodarczyk JH, Jayne F. Association between plasma folate and coronary disease independent of homocysteine. Am J Cardiol 2001;87:1003-1004.
28. Kanani PM, Sinkey C, Browning RL, Allaman M, Knapp H, Haynes WG. Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocysteinemia in humans. Circulation 1999;100:1161-1168.
29. Ford ES, Smith SJ, Stroup DF, Steinberg KK, Mueller PW, Thacker SB. Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies. Int J Epidemiol 2002;31:59-70.
30. Eichholzer M, Luthy J, Gutzwiller F, Stahelin HB. The role of folate, antioxidant vitamins and other constituents in fruit and vegetables in the prevention of cardiovascular disease: the epidemiological evidence. Int J Vitam Nutr Res 2001;71:5-17.
31. Harker LA, Slichter SJ, Scott CR, Ross R. Homocysteinemia: vascular injury and arterial thrombosis. N Engl J Med 1974;291:537-543.
32. Hofmann MA, Lalla E, Lu Y, et al. Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model. J Clin Invest 2001;107:675-683.
33. Peterson JC, Spence JD. Vitamins and progression of atherosclerosis in hyper-homocyst(e)inaemia. Lancet 1998;351:263-264.
34. Woo KS, Chook P, Lilin YI, Sanderson JE, Metreweli C, Celermajer DS. Folic acid improves arterial endothelial function in adults with hyperhomocysteinemia. J Am Coll Cardiol 1999;34:2002-2006.
35. Chia-Lun C, Kuo-Liong C, Yuan-Teh L. Effect of short-term vitamin (folic acid, vitamins B6 and B12) administration on endothelial dysfunction induced by post-methionine load hyperhomocysteinemia. Am J Cardiol 1999;84:1359-1361.
36. Vermeulen EGJ, Stehouwer CDA, Twisk JWR, et al. Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial. Lancet 2000;355:517-522.
37. Rimm EB, Ascherio A, Giovannucci E, Spiegelman D, Stampfer MJ, Willett W. Vegetable, fruit, and cereal fiber intake and risk of coronary heart disease among men. JAMA 1996;275:447-451.
38. Hu FB, Bronner L, Willet W, et al. Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA 2002;287:1815-1821.
39. Centers for Disease Control. Use of folic acid-containing supplements among women of childbearing age: United States, 1997. MMWR 1998;47:131-134.
40. Jacques PF, Sejhub J, Bostom AG, Wilson PWF, Rosenberg I. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med 1999;340:1449-1454.
41. Hernández-Díaz S, Werler MM, Louik C, Mitchell AA. Risk of gestational hypertension in relation to folic acid supplementation during pregnancy. Am J Epidemiol (in press).
42. Ray J, Laskin C. Folic acid and homocysteine metabolic defects and the risk of placental abruption, pre-eclampsia and spontaneous pregnancy loss: a systematic review. Placenta 1999;20:519-529.
43. Giovannucci E, Stampfer MJ, Colditz GA, et al. Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study. Ann Intern Med 1998;129:517-524.
44. Werler MM, Louik C, Mitchell AA. Achieving a public health recommendation for preventing neural tube defects with folic acid. Am J Public Health 1999;89:1637-1640.
45. Tice JA, Ross E, Coxson PG, et al. Cost-effectiveness of vitamin therapy to lower plasma homocysteine levels for the prevention of coronary heart disease: effect of grain fortification and beyond. JAMA 2001;286:936-943.
46. Parodi PW. The French paradox unmasked: the role of folate. Med Hypotheses 1997;49:313-318.
47. Stampfer MJ, Hu FB, Manson JE, Rimm EB, Willet W. Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med 2000;343:16-22.